Summary
Synthetic orally active angiotensin-converting enzyme (ACE) inhibitors have been successfully used in the treatment of congestive heart failure and hypertension, particularly in hypertensive subjects with increased renin-angiotensin-aldosterone-system activity. Adverse skin reactions, angioneurotic oedema and rapidly decreasing lung function in asthmatics have been reported following medication with ACE inhibitors. Furthermore, these drugs have been associated with a persistent dry cough in subjects without previous known bronchial hyper-reactivity. There is reason to believe that an ACE inhibitor-induced cough is due to an increased inflammatory state in the airways of susceptible individuals, and that this cough might thereby have pathophysiological features in common with the cough seen as an early symptom of asthma.
All inflammatory responses, wheal and flare reactions, infiltration of neutrophils, eosinophils, basophils and monocytes were enhanced by ACE inhibitors. A dose-response relationship for the proinflammatory effect of the ACE inhibitor has been demonstrated.
Similar content being viewed by others
References
Andersson RGG, Grundström N. Innervation of airway smooth muscle: efferent mechanisms. Pharmacology and Therapeutics 32: 107–130, 1987
Andersson RGG, Karlberg BE, Lindgren BR. Cough and other bronchial symptoms and skin disorders during treatment with ACE inhibitors (Swedish). Läkartidningen 84: 183–184, 1987
Appenzeller O, McAndrews EJ. The influence of the central nervous system on the triple response of Lewis. Journal of Nervous and Mental Disease 143: 190–194, 1966
Askenase PW. Role of basophils, mast cells and vasoamines in hypersensitivity reactions with a delayed time course. Progress in Allergy 23: 199–320, 1977
Avella J, Binder HJ, Madsen JE, Askenase PW. Effect of histamine H2-receptor antagonists on delayed hypersensitivity. Lancet 2: 624–626, 1978
Badian M, Eckert HG, Hajdu P, Irmisch R, Metzeger H. A food interaction study with a single dose of 10mg ramipril (HOE 498) in healthy men. Abstract. Deutsche Pharmalogische Gesellschaft, 27th Spring Meeting, Mainz, 1986
Ballett JJ, Merler E. The separation and reactivity in vitro of a subpopulation of human lymphocytes which bind histamine: correlation of histamine reactivity with cellular maturation. Cellular Immunology 24: 250–269, 1976
Bani-Sacchi T, Barrattini M, Bianchi S, et al. The release of histamine by parasympathetic stimulation in guinea-pig auricle and rat ileum. Journal of Physiology 371: 29–43, 1986
Bayliss WM. On the origin from the spinal cord of the vasodilator fibres in the hind limb, and on the nature of these fibres. Journal of Physiology 26: 173–209, 1901
Bernstein JE. Capsaicin in the treatment of dermatologic disease. Cutis 39: 352–353, 1987
Bernstein JE, Parish LC, Rapaport M, Rosenbaum MM, Roenigk Jr HH. Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. Journal of the American Academy of Dermatology 15: 504–507, 1986
Bernstein JE, Swift RM, Soltani K, Lorincz AL. Inhibition of axon reflex vasodilatation by topically applied capsaicin. Journal of Investigative Dermatology 76: 394–395, 1981
Bertoli L, Fusco M, Lo Cicero S, Miscallef E, Busnardo I. Influence of ACE inhibition on pulmonary haemodynamics and function in patients whom beta-blockers are contraindicated. Postgraduate Medical Journal 62 (Suppl. 1): 47–51, 1986
Blandina P, Barrattini M, Fantozzi R, Massini E, Brunellesci S, et al. Mediator release from isolated rat ileum in response to field stimulation. Agents and Actions 14: 405–409, 1984
Bolzano K, Arriaga J, Bernai R. The antihypertensive effects of lisinopril compared with atenolol in patients with mild to moderate essential hypertension. Journal of Cardiovascular Pharmacology 9: 43–47, 1987
Boulet LP, Cartier A, Thompson NC, Robert RS, Tech M, et al. Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposure. Journal of Allergy and Clinical Immunology 71: 399–406, 1983
Breton JL, Pasquier P, Dalphin JC, Louis JM, Jacobs A. Toux induite par un inhibiteur de l’enzyme de conversion de l’angiotensine. Revue de Pneumologie Clinique 43: 169, 1987
Brody I. Mast cell degranulation in the evolution of acute eruptive guttate psoriasis vulgaris. Journal of Investigative Dermatology 82: 460–464, 1984
Brown JH, Kissel JW, Lish PM. Studies on the acute inflammatory response: involvement of the central nervous system in certain models of inflammation. Journal of Pharmacology and Experimental Therapeutics 160: 231–242, 1968
Buck SH. Burks TF. Capsaicin: hot new pharmacological tool. Trends in Pharmacological Sciences 4: 84–87, 1983
Bucknall CE, Neilly JB, Carter R, Stevenson RD, Semple PF. Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors. British Medical Journal 296: 86–88, 1988
Burgoon CF, Burgoon JS, Baldridge CD. The natural history of herpes zoster. Journal of the American Medical Association 164: 265–269, 1957
Burkart W. Severe coughing during captopril and enalapril therapy. Correspondence. Canadian Medical Association Journal 135: 1070, 1986
Butterworth AE, David JR. Eosinophil function: current concepts. New England Journal of Medicine 304: 154–156, 1981
Carpenter S, Lynn B. Vascular and sensory responses of human skin to mild injury after topical treatment with capsaicin. British Journal of Pharmacology 73: 755–758, 1981
Casciere MA, Bull HG, Mumford RA, Patchett AA, Thornberry NA, et al. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin converting enzyme and the potentiation of substance P activity in vivo by captopril and MK 422: Molecular Pharmacology 25: 287–293, 1983
Case DB, Atlas SA, Laragh JH, Sealy JH, Sullivan PA, et al. Clinical experience with blockade of the renin-angiotensin-aldosterone-system by an oral converting enzyme inhibitor (SQ 14,225 captopril) in hypertensive patients. Progress in Cardiovascular Diseases 21: 195–206, 1978
Celander O, Folkow B. The nature and the distribution of afferent fibres provided with the axon reflexes arrangement. Acta Physiologica Scandinavia 29: 359–370, 1953
Chang MM, Leeman SF, Niall HD. Amino acid sequence of substance P. Nature, New Biology 86–87, 1971
Chapman LF. Mechanisms of the flare reaction in human skin. Journal of Investigative Dermatology 69: 88–97, 1977
Chapman LF, Goodell H. The participation of the nervous system in the inflammatory reaction. Annals of the New York Academy of Sciences 116: 990–1017, 1964
Chapman LF, Goodell H, Wolf HG. Increased inflammatory reaction induced by central nervous system activity. Transactions of the Association of American Physicians 72: 84–110, 1959
Cloutier MM, Loughlin GM. Chronic cough in children: a manifestation of airway hyperreactivity. Pediatrics 67: 6–12, 1981
Cockcroft DW, Ruffin RE, Dolovich J, Hargreave FE. Allergen-induced increase in non-allergic bronchial reactivity. Clinical Allergy 7: 503–513, 1977
Coleridge JCG, Coleridge HM. Afferent vagal C-fibre innervation of the lungs and airways and its functional significance. Reviews of Physiology, Biochemistry and Pharmacology 99: 1–110, 1984
Collier J, Fuller R. Capsaicin inhalation in man and the effects of sodium cromoglycate. British Journal of Pharmacology 81: 113–117, 1984
Corrao WM, Braham SS, Irwin RS. Chronic cough as the sole presenting manifestation of bronchial asthma. New England Journal of Medicine 300: 633–637, 1979
Coulter DM, Edwards IR. Cough associated with captopril and enalapril. British Medical Journal 294: 1521–1523, 1987
Couture R, Regoli D. Inactivation of substance P and its C-terminal fragments in rat plasma and its inhibition by captopril. Canadian Journal of Physiology and Pharmacology 59: 621–625, 1981
Crombie A, Manson P, McVey D, Smith MW, Smeeton VJ, et al. Once daily enalapril in general practice patients with mild to moderate essential hypertension. New Zealand Medical Journal 99: 503–504, 1986
Deepe Jr GS, Taylor CL, Srivastava L, Bullock WE. Impairment of granulomatous inflammatory response to Histoplasma capsulatum by inhibitors of angiotensin converting enzyme. Infection and Immunity 48: 395–401, 1984
DiBianco R. Adverse reactions with angiotensin converting enzyme (ACE) inhibitors. Medical Toxicology 1: 122–141, 1986
Dixon CMS, Fuller RW, Barnes PJ. The effect of an angiotensin converting enzyme inhibitor, ramipril, on bronchial response to inhaled histamine and bradykinin in asthmatic subjects. British Journal of Clinical Pharmacology 23: 91–93, 1987
Dreslinski GR. Incidence of cough associated with captopril therapy. Correspondence. Western Journal of Medicine 146: 622, 1987
Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA. Mechanisms of bronchial hyperreactivity in normal subjects following upper respiratory tract infection. American Review of Respiratory Diseases 113: 131–139, 1976
Enerbäck L. Mast cells in rat gastrointestinal mucosa. Acta Pathologica et Microbiologica Scandinavica 66: 289–322, 1966
Enerbäck L. The gut mucosal mast cell. Monographs in Allergy 17: 222–232, 1981
Epstein WL, Higuchi M, Izaki S, Fukuyama K. Effect of captopril on transplanted schistosome egg granulomas in skin. Journal of Investigative Dermatology 85: 212–215, 1985
Ewer TC, Stewart DE. Improvement in bronchial hyperresponsiveness in patients with moderate asthma after treatment with a hypnotic technique: a randomised controlled trial. British Medical Journal 293: 1129–1132, 1986
Farber EM, Nickoloff BJ, Recht B, Fraki JE. Stress, symmetry, and psoriasis: a possible role of neuropeptides. Journal of the American Academy of Dermatology 14: 305–311, 1986
Ferguson RK, Vlasses PH, Rotmensch HH. Clinical applications of the angiotensin converting enzyme inhibitors. American Journal of Medicine 77: 690–698, 1984
Ferreira SH. A bradykinin-potentiating factor (BPF) present in the venom of Bothrops jararaca. British Journal of Pharmacology and Chemotherapy 24: 163–169, 1965
Foreman JC. Neuropeptides and the pathogenesis of allergy. Allergy 42: 1–11, 1987
Foreman JC, Jordan CC. Neurogenic inflammation. Trends in Pharmacological Sciences 5: 116–119, 1984
Foreman JC, Jordan CC, Oehme P, Renner H. Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. Journal of Physiology 335: 449–465, 1983
Forsberg K, Karlsson JA. Cough induced by stimulation of capsaicin-sensitive sensory neurons in conscious guinea pigs. Acta Physiologica Scandinavica 128: 319–320, 1986
Frossard N, Barnes PJ. μ-Opoid receptors modulate non-cholinergic constrictor nerves in guinea pig airways. European Journal of Pharmacology 141: 519–522, 1987
Fuller RW, Choudry NB. Increased cough reflex associated with angiotensin-converting enzyme inhibitor cough. British Medical Journal 295: 1025–1026, 1987
Fuller RW, Dixon CMS, Cuss FMC, Barnes PJ. Bradykinin-induced bronchocontriction in humans. American Review of Respiratory Diseases 135: 176–180, 1987a
Fuller RW, Warren JB, McCusker M, Dollery CT. Effect of enalapril on the skin response to bradykinin in man. British Journal of Clinical Pharmacology 23: 88–90, 1987b
Furness PN, Goodfield MJ, MacLennan KA, Stevens A, Millard LG. Severe cutaneous reactions to captopril and enalapril: histological study and comparison with early mycosis fungoides. Journal of Clinical Pathology 39: 902–907, 1986
Fyhrquist F. Clinical pharmacology of the ACE inhibitors. Drugs 32 (Suppl. 5): 33–39, 1986
Gamse R, Lembeck F, Cuello AC. Substance P in the vagus nerve. Naunyn-Schmiedeberg’s Archives of Pharmacology 306: 37–44, 1979
Gamse R, Petsche U, Lembeck F, Jancso-Gabor A. Capsaicin to peripheral nerve inhibits axoplasmatic transport of substance P and somatostatin. Brain Research 239: 447–462, 1982
Golden JA, Nadel JA, Boushey HA. Bronchial hyperirritability in healthy subjects after exposure to ozone. American Review of Respiratory Diseases 118: 287–294, 1978
Golz F. Uber gefässerweitende Nerven. Pflugers Archiv 9: 174–197, 1874
Goodfield MJ, Millard LG. Severe cutaneous reactions to captopril. British Medical Journal 290: 1111, 1985
Green D, Tregear RT. The action of sensory irritants on the cats cornea. Journal of Physiology 175: 37–38, 1964
Hallright GP, Maling TBJ, Town GI. Enalapril and cough: case report. New Zealand Medical Journal 99: 66–67, 1986
Hanacek J, Davies A, Widdicombe JG. Influence of lung strech receptors on the cough reflex in rabbits. Respiration 45: 161–168, 1984
Heavey DJ, Fuller RW, Barnes PJ, Ind PW, Brown MJ, et al. Release of histamine by intradermal injection of substance P in man. Proceedings of the 9th International Congress in Pharmacology, p. 1067P, 1984
Hinsey JC, Gasser HS. The component of the dorsal root mediating vasodilatation and the Sherrington contracture. American Journal of Physiology 92: 679–689, 1930
Holzman MJ, Cunningham JM, Sheller JR, Irsigler GB, Nadel JA, et al. Effect of ozone on bronchial reactivity in atopic and nonatopic subjects. American Review of Respiratory Diseases 120: 1059–1067, 1979
Holzman MJ, Fabbri LM, O’Byrne PM, Gold BD, Aizawa H, et al. Importance of airway inflammation for hyperresponsiveness induced by ozone. American Review of Respiratory Diseases 127: 686–690, 1983
Hood S, Nicholls MG, Gilchrist NL. Cough with angiotensin converting enzyme inhibitors. New Zealand Medical Journal 100: 6–7, 1987
Hökfelt T, Kellert JO, Nilsson G, Pernow B. Experimental Immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurones. Brain Research 100: 235–252, 1975
Inman WHW. Enalapril-induced cough. Lancet 1: 1218, 1986
Israel-Biet D, Delaisements C, Chretien J. Enalapril-induced cough. Correspondence. Lancet 2: 918, 1986
Jancso N, Jancso-Gabor A. Dauerausschaltung der chemischen Schmerzempfindlichkeit durch Capsaicin. Naunyn-Schmiedeberg’s Archives of Pharmacology 236: 142–145, 1959
Jancso N, Jancso-Gabor A, Szolcsanyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. British Journal of Pharmacology 31: 138–151, 1967
Johansson IGM, Grundström N, Andersson RGG. Modulation of the airway excitatory neuronal pathways via alpha-2-adrenoceptors and opioid-receptors. Acta Physiologica Scandinavica 134: (Suppl. 575): 92, 1988
Johnson AR, Erdös EG. Release of histamine from mast cells by vasoactive peptides. Proceedings of the Society for Experimental Biology and Medicine 142: 1253–1256, 1973
Jorizzo JL, Sams WM, Jegasothy BV, Olansky AJ. Cimetidine as an immunomodulator: chronic mucocutaneous candidiasis as a model. Annals of Internal Medicine 92: 192–195, 1980
Kaliner M. Mast cell mediators and asthma. In Herzog & Perruchoud (Eds) Progress in respiratory research, Vol. 19, pp 17–29, Karger, Basel, 1985
Kaliner M, Orange RP, Austen KF. Immunological release of histamine and SRSA from the human lung, IV: enhancement by cholinergic and alpha-adrenergic stimulation. Journal of Experimental Medicine 136: 556–567, 1972
Karlsson JOG. Alpha2-adrenoceptors controlling fish pigment cells. Medical Dissertations, Linköping University, Sweden No 266, 1988
Kaufman J, Casanova JE, Riendl, Shleuter DP. Bronchial hyperreactivity and cough due to angiotensin-converting enzyme inhibitors. Chest 95: 544–548, 1989
Kay AB, Austen KF. The IgE-mediated release of an eosinophil leucocyte chemotactic factor from human lung. Journal of Immunology 107: 899–902, 1971
Khan MM, Sansoni P, Engleman EG, Melmon KL. Pharmacological effects of autacoids on subsets of T cells: regulation of expression/function of histamine-2 receptors by a subset of suppressor cells. Journal of Clinical Investigation 75: 1578–1583, 1985
Kiernan JA. The involvement of mast cells in vasodilatation due to axon reflexes in injured skin. Quarterly Journal of Experimental Physiology 57: 311–317, 1972
Laitinen LA, Elkin RB, Empey DW, Jacobs L, Mills J, et al. Changes in bronchial reactivity after administration of live attenuated influenza virus. Abstract. American Journal of Respiratory Diseases 113 (Suppl.): 194, 1976
Langley JN. On axon reflexes of the pre-ganglionic fibres. Journal of Physiology 25: 364–398, 1900
Lee CM, Arregui A, Iversen LL. Substance P degradation by rat brain peptidases: inhibition by SQ 20881. Biochemical Pharmacology 28: 553–556, 1979
Lembeck F. Sir Thomas Lewis’s nocisensor system, histamine and substance P-containing primary afferent nerves. Trends in Neurosciences 7: 106–109, 1983
Lernhardt EB, Ziegler MG. Cilazapril-induced cough. Clinical Research 35: 377A, 1987
Lewis T. The blood vessels of human skin and their responses, Shaw and Sons, London, 1927
Lewis T, Grant RT. Vascular reactions of the skin to injury. Heart 11: 209–265, 1924
Lewis T, Marvin HM. Observations relating to vasodilatation arising from antidromic impulses, to herpes zoster and trophic effects. Heart 14: 27–47, 1927
Lindgren BR. New aspects on the treatment of inflammatory reactions and broncho-obstruction in bronchial asthma. European Journal of Respiratory Diseases 70 (Suppl. 148): 1–72, 1987
Lindgren BR. New aspects on inflammatory reactions and cough following inhibition of angiotensin converting enzyme. Acta Physiologica Scandinavica 133 (Suppl. 573): 1–60, 1988
Lindgren BR, Andersson CD, Andersson RGG. Potentiation of inflammatory reactions in guinea-pig skin by an angiotensin converting enzyme inhibitor (HK 422). European Journal of Pharmacology 135: 383–387, 1987a
Lindgren BR, Andersson RGG, Ekström T, Grönneberg R, Karlberg BE, et al. Increased bronchial reactivity and inflammatory skin reactions in hypertensive subjects who developed cough during ACE-inhibitor therapy (Swedish). Hygiea 96: 203, 1987b
Lindgren BR, Andersson CD, Frödin T, Andersson RGG. Inhibitory effects of clonidine on allergic reactions in guinea pig skin. European Journal of Pharmacology 134: 339–343, 1987c
Lindgren BR, Brundin A, Andersson RGG. Inhibitory effects of clonidine on the allergen induced wheal and flare reactions in patients with extrinsic asthma. Journal of Allergy and Clinical Immunology 79: 941–947, 1987d
Lindgren BR, Grundström N, Andersson RGG. Comparison of the effects of clonidine and guanfacine on the histamine liberation from human mast cells and basophils and on the human bronchial smooth muscle activity. Drug Research 37: 551–553, 1987e
Lindgren BR, Rosenqvist U, Ekström T, Grönneberg R, Karlberg BE, et al. Increased bronchial reactivity and potentiated anti-IgE-induced skin responses in hypertensive subjects suffering from coughs during angiotensin converting enzyme inhibitor therapy. Chest, in press, 1989
Löwhagen O, Rak S. Modification of bronchial hyperreactivity after treatment with sodium cromoglycate during pollen season. Journal of Allergy and Clinical Immunology 75: 460–467, 1985
Lundberg JM, Hartling CR, Saria A. Substance P and capsaicin-induced contraction of human bronchi. Acta Physiologica Scandinavica 119: 49–53, 1983
Lundberg JM, Saria A, Theodorsson-Norheim E, Brodin E, Hua X, et al. Multiple tachykinins in capsaicin-sensitive afférents: occurrence release and biological effects with special reference to irritation of the airways. In Håkansson & Sundler (Eds) Tachykinin antagonists, pp. 159–169, Elsevier Science Publishers BV, Amsterdam, 1985
Lundblad L, Lundberg JM, Änggård A, Zetterström O. Capsaicin sensitive nerves and the cutaneous allergy reaction in man. Allergy 42: 20–25, 1987
Marceau F, Lussier A, Regoli D, Giroud JP. Pharmacology of kinins: their relevance to tissue injury and inflammation. General Pharmacology 14: 209–229, 1983
McNally EM. Cough due to captopril. Western Journal of Medicine 146: 226–228, 1987
Molnar J. Die pharmakologischen Wirkungen des Capsaicins, des scharf schmeckenden Wirkstoffes im Paprika. Artzneimittel-Forschung 15: 718–727, 1965
Morice AH, Brown MJ, Lowry R, Higenbottam T. Angiotensin converting enzyme and the cough reflex. Lancet 1: 1116–1118, 1987
Nadel JA. Inflammation and asthma. Journal of Allergy and Clinical Immunology 73: 651–653, 1984
Nagarathna R, Nagendra HR. Yoga for bronchial asthma: a controlled study. British Medical Journal 291: 1077–1079, 1985
Nash DT. Lisinopril cough. Texas Heart Institute Journal 13: 353–354, 1986
Newson B, Dahlström A, Enerbäck L, Ahlman H. Suggestive evidence for direct innervation of mucosal mast cells: an electron-microscopic study. Neuroscience 10: 565–570, 1983
Nicholls MG, Gilchrist NL. Sulindac and cough induced by converting inhibitors. Lancet 1: 872, 1987
Ollivier JP, Ducrocq MB, Droniou J. Un effet secondaire des inhibiteurs de l’enzyme de conversion: la toux. Presse Medicale 16: 759–761, 1987
Ondetti MA, Williams NJ, Sabo EF, Pluscec J, Weaver ER, et al. Angiotensin converting enzyme-inhibitors from the venom of Bothrops jararaca: isolation, elucidation of structure and synthesis. Biochemistry 10: 4033–4039, 1971
Ondetti MA, Rubin B, Cushman DW, Cheung HS, Sabo EF. Design of specific inhibitors of angiotensin converting enzyme: new class of orally active antihypertensive agents. Science 196: 441–444, 1977
Ostermann G, Freneaux E, Germain ML, Pasqual JC, Chousy H. Toux induite par les inhibiteurs de l’enzyme de conversion. Therapie 41: 404–405, 1986
Peacock AJ, Matthews AW. The effect of captopril on pulmonary haemodynamics and lung function in patients with chronic airflow obstruction. Thorax 41: 225, 1986
Portenoy RK. Postherpetic neuralgia: a workable treatment plan. Geriatrics 41: 34–48, 1986
Reid IA. Polypeptides. In Katzung (Ed.) Basic and clinical pharmacology, pp. 207–216, Lange Medical Publications, Los Altos, 1984
Riska H, Stenius-Aarniala B, Sovijärvi ARA. Comparison of the efficacy of an ACE-inhibitor and a calcium channel blocker in hypertensive patients: a preliminary report. Postgraduate Medical Journal 62 (Suppl. 1): 52–53, 1986
Rocha E Silva M, Beraldo WT, Rosenfeld G. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. American Journal of Physiology 156: 261–273, 1949
Rocklin RE. Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes. Journal of Clinical Investigations 57: 1051–1058, 1976
Rosetto BJ. Side effect of captopril and enalapril. Correspondence. Western Journal of Medicine 146: 1022, 1987
Rubin B, Antonaccio MJ, Horovitz ZP. Captopril, SQ 14,225 (D-3 mercapto-2-methyl propranoyl-L-proline): a new orally active inhibitor of angiotensin converting enzyme and antihypertensive agent. Progress in Cardiovascular Diseases 21: 183–194, 1978
Sala H, Abad J, Juanmiquel L, Plans C, Ruiz J, et al. Captopril and bronchial reactivity. Postgraduate Medical Journal 62 (Suppl. 1): 76–77, 1986
Saria A, Lundberg JM. Capsaicin pretreatment inhibits heat-induced oedema in the rat skin. Naunyn-Schmiedebergs Archives of Pharmacology 323: 341–342, 1983
Saria A, Theodorsson-Norheim E, Gamse R, Lundberg JM. Release of substance P and substance K-like immunoreactivities from the isolated perfused guinea pig lung. European Journal of Pharmacology 106: 207–208, 1985
Schapira M, Silver LD, Scott CF, Schmaier AH, Prograis Jr LJ, et al. Pre-kallikrein activation and high molecular weight kininogen consumption in hereditary angioedema. New England Journal of Medicine 308: 1050–1053, 1983
Scheel LD, Dobrogorski OJ, Mountain JT, Svirbely JL, Stokinger HE. Physiologic, biochemical, immunologic, and pathologic changes following ozone exposure. Journal of Applied Physiology 14: 67–80, 1959
Schrier DJ, Ripani LM, Katzenstein A-L. Role of angiotensin converting enzyme in Bacille Calmette-Guerin-induced granulomatous inflammation: increased angiotensin converting enzyme levels in lung lavage and suppression of inflammation with captopril. Journal of Clinical Investigation 69: 651–657, 1982
Semple PF, Herd GW. Cough and wheeze caused by inhibitors of angiotensin-converting enzyme. New England Journal of Medicine 61: 314, 1986
Sesoko S, Kaneko Y. Cough associated with the use of captopril. Archives of Internal Medicine 145: 1524, 1985
Siems WE, Heder G, Jentzsch KD, Rathsack R, Kertscher U, et al. Wechelwirkungen des angiotensin-converting Enzyms mit Substanz P. Die Pharmazie 42: 153–156, 1987
Simonsson BG, Skoogh B-E, Bergh NP, Andersson RGG, Svedmyr N. In vivo and in vitro effect of bradykinin on bronchial motor tone in normal subjects and patients with airway obstruction. Respiration 30: 378–388, 1973
Skidgel RA, Engelbrecht S, Johnson AR, Erdös EG. Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase. Peptides 5: 769–776, 1984
Skotfisch G, Donnerer J, Petronijevic S, Saria A, Lembeck F. Release of histamine by neuropeptides from the perfused rat hindquarter. Naunyn-Schmiedeberg’s Archives of Pharmacology 322: 153–157, 1983
Skotfisch G, Savitt JM, Jacobowitz DM. Suggestive evidence for a functional unit between mast cells and substance P fibres in the rat diaphragm and mesentery. Histochemistry 2: 5–8, 1985
Steinman TI, Silvia P. Acute renal failure, skin rash and eosinophilia associated with captopril therapy. American Journal of Medicine 75: 154–156, 1983
Stricker S. Untersuchungen über die Gefassnerven-Wurtzeln des Ishiadicus. Sitzungsberichte der Kaiserlichen Akademie der Wissenschaften, Wien, LXXIV Ab III: 173–185, 1876
Stumpe KO, Kolloch R, Overlack A. Captopril and enalapril: evaluation of therapeutic efficacy and safety. Practical Cardiology 10: 111–124, 1984
Suarez M, Ho PW, Johnson ES, Perez G. Angioneurotic edema, agranulocytosis, and fatal septicemia following captopril therapy. American Journal of Medicine 81: 336–338, 1986
Swartz A, Askenase PW, Gershon RK. Histamine inhibition of the in vitro induction of cytotoxic T-cell responses. Immunopharmacology 2: 179–190, 1980
Targhetta R, Godard PH, Calvayrac P, Mimran A, Balmes P, et al. Tolerance du captopril chez l’asthmatique. Presse Medicale 13: 1699, 1984
Theriault E, Otsuka M, Jessel T. Capsaicin evoked release of substance P from primary sensory neurones. Brain Research 170: 209–213, 1979
Torebjörk HE, Hallin RG. Identification of afferent C units in intact human skin. Brain Research 67: 387–403, 1974
Toth-Kasa I, Gabor-Jancso J, Obal F, Husz S, Simon N. Involvement of sensory nerve endings in the cold and heat urticaria. Journal of Investigative Dermatology 80: 34–36, 1983
Town GI, Hallwright GP, Maling T, O’Donnell TV. Angiotensin converting enzyme inhibitors and cough. New Zealand Medical Journal 100: 161–163, 1987
Umemoto L, Poothullil J, Dolovich J, Hargreave FE. Factors which influence late cutaneous allergic responses. Journal of Allergy and Clinical Immunology 58: 60–68, 1976
Uotila P, Punnonen K, Tammivaara R, Jansen CT. Detection of leukotrienes in the serum of asthmatic and psoriatic patients. Acta Dermato-Venerologica 66: 381–385, 1986
Van Hees J, Gybels JM. Pain related to single afferent C fibres in human skin. Brain Research 48: 397–400, 1972
Venge P, Dahl R, Hällgren R. Enhancement of F XII-dependent reactions by eosinophil cationic protein. Thombosis Research 14: 641–649, 1979
von Euler US, Gaddum JH. An unidentified depressive substance in certain tissue extracts. Journal of Physiology 72: 74–87, 1931
Way WL, Way EL. Narcotic analgetics and antagonists. In Katzung (Ed.) Basic and clinical pharmacology, pp. 339–352, Lange Medical Publications, Los Altos, 1984
Webb D, Benjamin N, Collier J, Robinson B. Enalapril-induced cough. Lancet 2: 1094, 1986
Webb DJ, Benjamin N, Collier JG, Robinson BF. Cough associated with captopril and enalapril. British Medical Journal 295: 272, 1987
Widdicombe JG. Innervation of the airways. In Herzog & Perruchoud (Eds) Progress in respiratory research, Vol. 19, pp. 8–16, Karger, Basel, 1985
Wiesner-Henzel L, Schulz B, Vakilzadeh F, Czarnetzki BM. Electron microscopical evidence for a direct contact between nerve fibres and mast cells. Acta Dermato-Venerologica 61: 465–499, 1981
Wilkin JK, Hammond JJ, Kirkendall WM. The captopril-induced eruption. Archives for Dermatological Research 116: 902–905, 1980
Winkelmann RK. Total plasma kininogen in psoriasis and atopic dermatitis. Acta Dermato-Venerologica 64: 261–263, 1984
Witte PU, Irmisch R, Hajdu P, Metzger H. Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects. European Journal of Clinical Pharmacology 27: 577–581, 1984
Woo J, Woo KS, Kin T, Vallance-Owen J. A single-blind, randomized, cross-over study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly. Archives of Internal Medicine 147: 1386–1389, 1987
Wood SM, Mann RD. Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors. British Medical Journal 294: 91–92, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lindgren, B.R., Andersson, R.G.G. Angiotensin-Converting Enzyme Inhibitors and Their Influence on Inflammation, Bronchial Reactivity and Cough. Med Toxicol Adverse Drug Exp 4, 369–380 (1989). https://doi.org/10.1007/BF03259918
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03259918